Company profile for Farmhispania

Farmhispania-PSE
News

DATA COMPILATION
#PharmaFlow

PharmaCompass

Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Related CompaniesRelated Companies

About

Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipment, new technologies, and enhanced capabilities. Significant investments include the implementation of hydrogenation technologies in 2007, HPAPI handling capabilities in 2010, highly potent fermentation capabilities in 2014, and the expansion of large-scale preparative chromatography in 2015. Additionally, Farmhispania Group actively collaborates on numerous projects with various universities and research organizations both nationally and internationally.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Passeig Riu Besòs, nº 9-10 08160 Montmeló (Barcelona)
Telephone
Telephone
+34 935720190
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $tile1

Filename: tabs/exhibitions.php

Line Number: 43

Backtrace:

File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler

File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view

File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create

File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include

File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include

File: /var/www/html/application/controllers/PharmaServices.php
Line: 4640
Function: view

File: /var/www/html/index.php
Line: 224
Function: require_once

CPhI India 2024

CPhI India 2024

Not Confirmed

envelop Contact Supplier

CPhI India 2024

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/farmhispania-party-content-58506.pdf

    https://www.pharmacompass.com/pdf/party/content/farmhispania-party-content-38064.pdf

DATA COMPILATION #PharmaFlow

read-more
read-more
DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   

Impressions: 5960

https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

#PharmaFlow by PHARMACOMPASS
24 Oct 2024

NEWS #PharmaBuzz

read-more
read-more

https://www.farmhispaniagroup.com/fhg-to-sponsor-felix-serratosa-conference/

PRESS RELEASE
30 Jan 2023

https://www.farmhispaniagroup.com/fhgs-montmelo-site-successfully-inspected-by-anvisa/

PRESS RELEASE
14 Nov 2022

https://www.farmhispaniagroup.com/framhispania-group-awarded-with-the-first-cep-for-everolimus/

PRESS RELEASE
02 Feb 2021

https://www.farmhispaniagroup.com/new-multipurpose-manufacturing-building-at-the-montmelo-barcelona-site/

PRESS RELEASE
12 Sep 2020

https://www.farmhispaniagroup.com/medicines-for-europe-statement-on-covid-19-coronavirus/

PRESS RELEASE
16 Mar 2020

https://www.farmhispaniagroup.com/farmhispania-group-in-the-3rd-annual-markets-and-markets-high-potent-medicines-conference-milan/

PRESS RELEASE
04 Dec 2019

01

Metformin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF CN, RU arrow-down AUDIT
Farmhispania

02

Rocuronium Bromide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF CN, RU arrow-down AUDIT
Farmhispania

03

Atracurium Besylate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF CN, RU arrow-down AUDIT
Farmhispania

04

Benazepril Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF CN arrow-down AUDIT
Farmhispania

05

Cisatracurium Besylate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF CN, RU arrow-down AUDIT
Farmhispania

06

Enalapril Maleate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Farmhispania

07

Everolimus

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Farmhispania

08

Gefitinib

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
Farmhispania

09

Gemcitabine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
Farmhispania

10

Milrinone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma Manufacturing 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF VMF EU arrow-down AUDIT
Farmhispania
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KEY PRODUCTS

read-more
read-more

TOP RANKED SUPPLIER FOR:

Sponsored Ads.
full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view

Services

Discover the service capabilities from this company

API Manufacturing

Discover their expertise for : API Manufacturing

API & Drug Product Development

Discover their expertise for : API & Drug Product Development

KEY SERVICES

read-more
read-more

TOP RANKED SUPPLIER FOR:

Biocatalysis
full-view
Jet Mill Micronizer
full-view
End-to-end CDMO for ADCs
full-view
Continuous Processes For Hazardous Reactions
full-view

Inspections and registrations

Check the inspections & registration from this company

ABOUT THIS PAGE

Contact Farmhispania and get a quotation

Farmhispania is a supplier offers 44 products (APIs, Excipients or Intermediates).

Find a price of Metformin bulk with DMF, CEP, JDMF offered by Farmhispania

Find a price of Rocuronium Bromide bulk with DMF, CEP, JDMF offered by Farmhispania

Find a price of Atracurium Besylate bulk with DMF, CEP offered by Farmhispania

Find a price of Benazepril Hydrochloride bulk with DMF, CEP offered by Farmhispania

Find a price of Cisatracurium Besylate bulk with DMF, CEP offered by Farmhispania

Find a price of Enalapril Maleate bulk with DMF, CEP offered by Farmhispania

Find a price of Everolimus bulk with DMF, CEP offered by Farmhispania

Find a price of Gefitinib bulk with CEP, JDMF offered by Farmhispania

Find a price of Gemcitabine bulk with CEP, JDMF offered by Farmhispania

Find a price of Milrinone bulk with DMF, JDMF offered by Farmhispania

Find a price of Pemetrexed Disodium bulk with CEP, JDMF offered by Farmhispania

Find a price of Sugammadex Sodium bulk with DMF, JDMF offered by Farmhispania

Find a price of Ramipril bulk with CEP offered by Farmhispania

Find a price of Captopril bulk with CEP offered by Farmhispania

Find a price of Decitabine bulk with DMF offered by Farmhispania

Find a price of Deutetrabenazine bulk with DMF offered by Farmhispania

Find a price of Metformin bulk with DMF offered by Farmhispania

Find a price of Quinapril bulk with DMF offered by Farmhispania

Find a price of Rocuronium Bromide bulk with CEP offered by Farmhispania

Find a price of Tacrolimus bulk with DMF offered by Farmhispania

Find a price of GEMCITABINE HYDROCHLORIDE USP bulk with DMF offered by Farmhispania

Find a price of Fexofenadine Hydrochloride bulk offered by Farmhispania

Find a price of Atropine bulk offered by Farmhispania

Find a price of Atropine Sulfate bulk offered by Farmhispania

Find a price of Cannabidiol bulk offered by Farmhispania

Find a price of Delapril Hydrochloride bulk offered by Farmhispania

Find a price of Desloratadine bulk offered by Farmhispania

Find a price of Deucravacitinib bulk offered by Farmhispania

Find a price of Loratadine bulk offered by Farmhispania

Find a price of Methotrexate bulk offered by Farmhispania

Find a price of Midostaurin bulk offered by Farmhispania

Find a price of Palonosetron bulk offered by Farmhispania

Find a price of Perindopril Arginine bulk offered by Farmhispania

Find a price of Perindopril Erbumine bulk offered by Farmhispania

Find a price of Pirfenidone bulk offered by Farmhispania

Find a price of Relugolix bulk offered by Farmhispania

Find a price of Sirolimus bulk offered by Farmhispania

Find a price of Staurosporine bulk offered by Farmhispania

Find a price of Tapentadol bulk offered by Farmhispania

Find a price of Tetrabenazine bulk offered by Farmhispania

Find a price of Trandolapril bulk offered by Farmhispania

Find a price of Valbenazine Tosylate bulk offered by Farmhispania

Find a price of Vecuronium Bromide bulk offered by Farmhispania

Find a price of Zavegepant HCl bulk offered by Farmhispania

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty